FDA approves tafasitamab-cxix for relapsed or refractory follicular lymphoma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-tafasitamab-cxix-relapsed-or-refractory-follicular-lymphoma?utm_medium=email&utm_source=govdelivery